跳至主要内容
临床试验/ACTRN12617001418369
ACTRN12617001418369招募中4 期

The safety and pharmacokinetics of metformin in heart failure

St Vincent's Hospital Sydney0 个研究点目标入组 50 人开始时间: 2017年10月9日最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Study B & C - Patients with heart failure (NYHA Grade I-III, Preserved or Reduced Ejection Fraction)
  • Patients not currently taking metformin
  • Study A - Patients with heart failure (NYHA Grade I-III, Preserved or Reduced Ejection Fraction)
  • Patients currently taking metformin

排除标准

  • Patients who are currently on metformin
  • Patients who have type II diabetes mellitus (Study B & C Only)
  • Women lactating, pregnant or of childbearing potential who are not willing to avoid becoming pregnant during the study.
  • Patients with a history of a psychological illness or condition such as to interfere with the patient's ability to understand the requirements of the study.
  • Patients with a history of lactic acidosis.
  • Patients with grade IV heart failure
  • Patients with chronic kidney disease ( creatinine clearance < 30 ml/min)

研究者

发起方
St Vincent's Hospital Sydney

相似试验